Skip to main content
A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer
DESNT: A Poor Prognosis Category of Human Prostate Cancer
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets
Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data
Mutational signatures of ionizing radiation in second malignancies
Prostate Single Nucleotide Polymorphism Provides a Crucial Clue to Cancer Aggression in Active Surveillance Patients
A gene expression based predictor for high risk myeloma treated with intensive therapy and autologous stem cell rescue
Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study
The evolutionary history of lethal metastatic prostate cancer
Benzo "Equation missing" pyrene-induced DNA adducts and gene expression profiles in target and non-target organs for carcinogenesis in mice
-
Our research
-
Technology platforms
-
Training and events
-
Stories and impact
